Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...

Unlock the potential of GLP-1 therapies! Join experts to explore cutting-edge strategies for managing cardiovascular & ...

Two clinical trials of dementia care programs report negative results in terms of patient neuropsychiatric symptoms and ...

The probability of freedom from recurrence 5 years after surgical excision was higher than with a noninvasive approach in patients with nodular basal cell carcinoma, although the analysis did not show ...

Having peers facilitate virtual visits may lead to many more patients with hepatitis C receiving treatment and clearing the ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

A new advisory from the American Heart Association strongly endorses endovascular treatment for patients with large core ...

Teens and young adults with anxiety, ADHD, or sleep disorders were more likely to have a diagnosis of addiction to sedatives ...

A new study suggests clinical utility of the first FDA-approved genetic test to help gauge an individual’s risk for opioid ...

Predicting who will transition from acute to chronic pain is the “holy grail” of pain neuroscience. A novel biomarker ...

Two newer adiposity measures incorporating waist circumference predicted periodontitis better than body mass index, reported ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...